Skip to main content
    A

    American Shared Hospital Service (AMS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • AMEX

    $1.08
    +0.01 (+0.46%)

    Market Cap: $7.18M

    Last updated: Nov 17, 2026 at 10:44 AM ET

    American Shared Hospital Service (AMS) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    American Shared Hospital Service (AMS) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, American Shared Hospital Service reported EPS of -$0.09, below the $0.01 estimate. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    27%(3/11)
    Avg Surprise
    -214.50%

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.01
    2 analysts
    Revenue Consensus
    $8.72M
    Range$8.46M - $9.06M
    2 analysts

    Next Report

    AMS has an expected report date of Mar 29, 2027.

    AMS Earnings Call

    The latest AMS earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    Earnings History

    Of the 11 quarters below that had an estimate, AMS beat 3 and missed 8. Revenue for the quarter ended Sep 30, 2026 was $7.62M, up 6.3% from $7.17M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.09$0.01$0.01 - $0.01-1000.00%MissN/A10 up, 1 downNov 12, 2026$7.62M
    Jun 30, 2026-$0.07-$0.02-$0.02 - -$0.02-250.00%MissN/A10 up, 0 downAug 13, 2026$8.43M
    Mar 31, 2026-$0.09-$0.01-$0.01 - -$0.01-800.00%MissN/A10 up, 0 downMay 14, 2026$7.08M
    Dec 31, 2025-$0.09$0.02$0.02 - $0.02-550.00%MissN/A10 up, 0 downMar 31, 2026$7.73M
    Sep 30, 2025$0.00$0.04N/A-106.50%MissN/A10 up, 0 downNov 13, 2025$7.17M
    Jun 30, 2025-$0.04-$0.07-$0.07 - -$0.07+42.86%Beat-106.9%10 up, 0 downAug 13, 2025$7.07M
    Mar 31, 2025-$0.10$0.04$0.04 - $0.04-350.00%Miss-600.0%10 up, 0 downApr 4, 2025$6.11M
    Dec 31, 2024-$0.22$0.01$0.01 - $0.01N/AN/A-469.5%10 up, 1 downMar 26, 2025$9.07M
    Sep 30, 2024-$0.03$0.08$0.08 - $0.08-137.50%Miss-250.0%10 up, 0 downNov 13, 2024$7.00M
    Jun 30, 2024$0.58$0.08N/A+625.00%BeatN/A10 up, 0 downAug 14, 2024$7.06M
    Mar 31, 2024$0.02$0.03$0.03 - $0.03-33.33%Miss-33.3%10 up, 0 downMay 14, 2024$5.22M
    Dec 31, 2023$0.06$0.02$0.02 - $0.02+200.00%Beat+50.0%10 up, 0 downMar 27, 2024$5.70M
    Sep 30, 2023$0.02N/AN/AN/AN/A-60.3%N/AN/ANov 13, 2023$5.13M
    Jun 30, 2023-$0.02N/AN/AN/AN/A-121.9%N/AN/AAug 14, 2023$5.57M
    Mar 31, 2023$0.03N/AN/AN/AN/A-25.0%N/AN/AMay 12, 2023$4.92M
    Dec 31, 2022$0.04N/AN/AN/AN/A0.0%N/AN/AMar 24, 2023$5.04M
    Sep 30, 2022$0.05N/AN/AN/AN/A+404.0%N/AN/ANov 10, 2022$4.83M
    Jun 30, 2022$0.08N/AN/AN/AN/AN/AN/AN/AAug 11, 2022$5.03M
    Mar 31, 2022$0.04N/AN/AN/AN/AN/AN/AN/AMay 12, 2022$4.85M
    Dec 31, 2021$0.04N/AN/AN/AN/A+769.6%N/AN/AMar 24, 2022$4.69M
    Sep 30, 2021$0.01N/AN/AN/AN/AN/AN/AN/ANov 10, 2021$4.10M
    Jun 30, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AAug 12, 2021$4.48M
    Mar 31, 2021-$0.95N/AN/AN/AN/A-3266.7%N/AN/AApr 6, 2021$4.36M
    Dec 31, 2020$0.00N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$4.61M
    Sep 30, 2020-$0.03N/AN/AN/AN/A-200.0%N/AN/ANov 12, 2020$4.67M
    Jun 30, 2020-$0.08N/AN/AN/AN/A-900.0%N/AN/AAug 14, 2020$3.99M
    Mar 31, 2020$0.03N/AN/AN/AN/A-40.0%N/AN/AApr 2, 2020$4.57M
    Dec 31, 2019-$0.02N/AN/AN/AN/A-173.3%N/AN/AMar 31, 2020$4.79M
    Sep 30, 2019$0.03N/AN/AN/AN/A0.0%N/AN/ANov 7, 2019$5.30M
    Jun 30, 2019$0.01N/AN/AN/AN/A-80.0%N/AN/AAug 13, 2019$5.20M
    Mar 31, 2019$0.05N/AN/AN/AN/A-28.6%N/AN/AMay 9, 2019$5.32M
    Dec 31, 2018$0.03N/AN/AN/AN/AN/AN/AN/AMar 28, 2019$4.77M
    Sep 30, 2018$0.03N/AN/AN/AN/A+50.0%N/AN/ANov 8, 2018$4.47M
    Jun 30, 2018$0.05N/AN/AN/AN/A+150.0%N/AN/AAug 9, 2018$5.17M
    Mar 31, 2018$0.07N/AN/AN/AN/A+40.0%N/AN/AMay 10, 2018$5.30M
    Dec 31, 2017-$0.02N/AN/AN/AN/A-140.0%N/AN/AMar 26, 2018$5.08M
    Sep 30, 2017$0.02N/AN/AN/AN/A-74.8%N/AN/ANov 13, 2017$4.61M
    Jun 30, 2017$0.02N/AN/AN/AN/A-66.7%N/AN/AAug 10, 2017$4.95M
    Mar 31, 2017$0.05N/AN/AN/AN/A+197.6%N/AN/AMay 15, 2017$4.91M
    Dec 31, 2016$0.05N/AN/AN/AN/A+443.5%N/AN/AMar 23, 2017$5.06M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.23, after $0.35 the year before. It was $0.21 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.23-166.8%
    Dec 31, 2024$0.35+276.5%
    Dec 31, 2023$0.09-56.0%
    Dec 31, 2022$0.21N/A
    Dec 31, 2021-$0.91N/A
    Dec 31, 2020-$0.08-210.9%
    Dec 31, 2019$0.07-62.2%
    Dec 31, 2018$0.18+157.1%
    Dec 31, 2017$0.07-66.1%
    Dec 31, 2016$0.21N/A

    Earnings Calls

    The 7 most recent earnings calls are listed below; the latest, 2026Q1 for the period ended Mar 31, 2026, runs about 2,700 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q1Mar 31, 20262,6537
    2025Q4Dec 31, 20253,0687
    2025Q3Sep 30, 20253,3157
    2025Q2Jun 30, 20252,7736
    2025Q1Mar 31, 20252,6156
    2024Q3Sep 30, 20244,1907
    2024Q2Jun 30, 20242,9526

    2026Q1 Earnings Call

    Opening remarks

    Kirin Smith Investor Relations Thank you, operator, and thank you, everyone, for joining us today. AMS' first quarter 2026 earnings press release was issued earlier today. If you need a copy, it can be accessed on the company's website at www.ashs.com under the Investors section. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. Please note that various remarks that may be made on this conference call about future expectations, plans, and prospects for the company constitute forward-looking statements for the purposes of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the company's filings with the SEC, including our Form 10-Q for the quarter ended 03/31/2026. The company assumes no obligation to update the information contained in this conference call. Before I turn the call over to management, I would like to remind everyone about our Q&A policy, where we provide each participant the time to ask one question and one follow-up. As always, we will be happy to take additional questions offline. With that, I would now like to turn the call over to Raymond C. Stachowiak, Executive Chairman. Raymond, please go ahead.

    Raymond C. Stachowiak Executive Chairman Thank you, Kirin, and thank you all for joining us today. First, I will start with an update on our recent management changes and then we will provide some key highlights from the quarter and give further detail on our enthusiasm and confidence in our growth prospects. In late April, we announced a leadership transition, with Gary Delanois stepping down as our Chief Executive Officer for personal reasons and the Board appointing Craig K. Tagawa as our Interim CEO. We thank Gary for his valuable contributions and wish him the best of luck in his future endeavors. Craig brings more than 35 years of experience with the company, including leadership roles as our President, Chief Operating Officer, and Chief Financial Officer. His deep operational and financial expertise along with his long history with the organization positions him well to lead the company through its next phase. We are confident in the team's ability to continue driving the execution, increasing treatment volumes, and supporting revenue growth. As we look at the first quarter, and a continuation into the second quarter, we are encouraged by the continued progress across our network, particularly in terms of increasing treatment volumes and improved center-level performance. I am pleased to report that we are continuing to see volumes trending positively into our second quarter as we remain extremely focused on strong execution.

    Frequently Asked Questions About AMS

    When is American Shared Hospital Service's next earnings date?

    American Shared Hospital Service's next earnings report is expected for Mar 29, 2027.

    Did AMS beat earnings estimates last quarter?

    No. American Shared Hospital Service reported EPS of -$0.09 for the quarter ended Sep 30, 2026, below the $0.01 estimate by 1000.00%.

    What EPS do analysts expect from AMS next quarter?

    The consensus EPS estimate for American Shared Hospital Service for the quarter ending Dec 31, 2026 is $0.01 from 2 analysts, with estimates from $0.01 to $0.01.

    How often does AMS beat earnings estimates?

    American Shared Hospital Service beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -393.89%.